NCT01575548 2026-03-18
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
50 trialsNCT03775265 2026-03-18
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT03793166 2026-03-18
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05092958 2026-03-18
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06524544 2026-03-18
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT03055013 2026-03-17
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00942331 2023-10-16
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01198158 2019-03-06
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00003734 2016-07-21
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00047138 2014-06-24
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00110214 2014-05-09
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
National Cancer Institute (NCI)
Phase 3 Completed
NCT00767286 2014-01-28
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00398281 2014-01-10
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00553124 2014-01-10
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00553345 2014-01-10
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00053820 2013-12-19
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003814 2013-12-18
Eflornithine in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00024349 2013-12-18
Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003014 2013-12-04
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003290 2013-12-04
Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002703 2013-11-06
Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003725 2013-11-06
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005075 2013-11-06
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00033436 2013-09-20
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00274950 2013-09-17
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00363285 2013-08-26
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00376792 2013-08-26
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00324298 2013-08-12
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
National Cancer Institute (NCI)
Phase 3 Completed
NCT00492258 2013-08-12
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00796458 2013-08-12
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01094964 2013-08-12
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00110162 2013-08-07
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00589537 2013-08-07
Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00632138 2013-08-07
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
National Cancer Institute (NCI)
Phase 3 Completed
NCT00004219 2013-08-02
Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005590 2013-08-02
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002596 2013-06-26
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
National Cancer Institute (NCI)
Phase 3 Completed
NCT00082927 2013-06-26
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
National Cancer Institute (NCI)
Phase 3 Completed
NCT00255606 2013-06-26
Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00316927 2013-06-26
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00018941 2013-06-17
Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00006034 2013-05-15
Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00005623 2013-03-26
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002723 2013-02-28
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00394511 2013-02-11
Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01087268 2011-07-15
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00046943 2011-02-21
Atrasentan in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002881 2010-11-09
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00048841 2010-03-02
Prevention of Osteoporosis in Men With Prostate Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Completed
NCT00005966 2009-02-05
Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
National Cancer Institute (NCI)
Phase 3 Completed